Daiichi Sankyo & AstraZeneca’s Enhertu receives 2024 Prix Galien USA Award for Best Biotechnology Product: Tokyo Monday, November 11, 2024, 09:00 Hrs [IST] Daiichi Sankyo and As ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being ...

Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, is kicking off NEXT New York 2024, its premier life sciences conference. Uniting more than ...

at 08:05 Daiichi Sankyo to Showcase TURALIO® Research in Patients ... at 08:05 Medidata Unveils Transformative Solutions and Collaborations at NEXT New York, Driving Paradigm Shift in Life Sciences ...

Neurogene has reported encouraging efficacy results with its gene therapy for rare genetic disorder Rett syndrome, but ...

MSD and Daiichi Sankyo have revealed some of the ... according to Charles Rudin of Memorial Sloan Kettering Cancer Center in New York, who presented the data at WCLC. On safety, there was a ...

Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a digital health company transforming care through the power of portable, ...

One investigation discussed during the call involves sales reps in China allegedly changing genetic testing results to secure reimbursement for Tagrisso.

Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

The three big airports that serve New York City have proposed allowing concession prices to rise and adding a surcharge to cover higher wages and improved worker benefits. By Patrick McGeehan ...

‘This is a clear violation of FEMA’s core values and principles to help people regardless of their political affiliation,’ the agency says. A city tram is torched to a chorus of anti-Jewish slurs as ...